Julie Hoover-Fong

Professor

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julie Hoover-Fong is a Professor at Johns Hopkins University, USA. Her research primarily focuses on achondroplasia and skeletal dysplasias, including the diagnosis, management, and treatment considerations for patients with these conditions. She has contributed to significant publications regarding the implementation of vosoritide therapy and the natural history of achondroplasia, addressing both clinical and anthropometric concerns in affected individuals.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Laura Southgate

Senior Lecturer in Genetics

St George’s, University of London

UNITED KINGDOM

View details

Rajiv David Machado

Visiting Lecturer

St George’s, University of London

UNITED KINGDOM

View details

Oliver Semler

head of department

University Hospital

GERMANY

View details

Keita Okada

Lecturer

University of Tokyo

JAPAN

View details

Charlie Fairhurst

Head of Service

Guy's and St Thomas' NHS Foundation Trust

UNITED KINGDOM

View details

Marta Bleda

Head of Bioinformatics

UNITED KINGDOM

View details

Henry Chambers

Professor of Clinical Orthopedic Surgery

University of California, San Diego

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie Hoover-Fong

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Considerations for Anthropometry Specific to People with Disproportionate Short Stature

Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment

International Expert Opinion on Standard of Care for Patients With Schinzel‐Giedion Syndrome: A Modified Delphi Study

International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia

Biallelic variants of ATP13A3 cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.

Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study—a multi-center retrospective cohort study of achondroplasia in the US

Current state of the art in treatment of Mendelian disease: Skeletal dysplasias

Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.

Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.

Collaborators (7)

Laura Southgate

Rajiv David Machado

Oliver Semler

Keita Okada

Charlie Fairhurst

Marta Bleda

Henry Chambers

Make your next move.